Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAviva Regulatory News (AV.)

Share Price Information for Aviva (AV.)

Share Price is delayed by 15 minutes
Get Live Data
619.00    6.00 (0.98%)
Bid:
622.20
Ask:
622.60
Spread: 0.40 (0.064%)
Market Cap: £18.52b
AV. Live PriceLast checked at - London Stock Exchange

Intraday Aviva Share Chart

2025 Results Announcement

5 Mar 2026 07:00

RNS Number : 4029V
Aviva PLC
05 March 2026
 

 

 

 

05 March 2026

 

Aviva plc

2025 Full Year Results and Annual Report and Accounts

 

Aviva plc's Full Year Results and Annual Report and Accounts for the year ending 31 December 2025 are available at:

http://www.rns-pdf.londonstockexchange.com/rns/4029V_1-2026-3-4.pdf

http://www.rns-pdf.londonstockexchange.com/rns/4029V_2-2026-3-4.pdf

The Full Year Results and Annual Report and Accounts will be available shortly on the Aviva corporate website at www.aviva.com/investors/results-presentations-reports and both documents have been submitted in full unedited text to the Financial Conduct Authority's National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Dividend declaration

Aviva announces a final dividend of 26.2 pence per share on Ordinary shares of 32 17/19 pence. Subject to shareholder approval at the 2026 Annual General Meeting and the condition below, the final dividend for the year ending 31 December 2025 will be paid on 14 May 2026 to shareholders on the Register of Members at the close of business on 27 March 2026. Holders of Aviva American Depository Receipts will be paid the dividend approximately four business days after the payment to Ordinary shareholders. The last election date for the Dividend Reinvestment Plan is 22 April 2026. The dividend is conditional upon the Directors not having determined (at their discretion) to cancel the dividend at any point prior to its payment.

In compliance with the rules issued by the Prudential Regulation Authority and other regulatory requirements to which the Group is subject, the dividend is required to remain cancellable at any point prior to it becoming due and payable. The dividend is therefore conditional upon the Directors not having determined (at their discretion) to cancel the dividend at any point prior its payment. The Directors have no intention of exercising this cancellation right, other than where they determine it may be necessary or appropriate to do so as a result of legal or regulatory requirements (including without limitation if, prior to payment, the Group ceases to hold capital resources equal to or in excess of its Solvency Capital Requirement, or if that would be the case if the dividend were paid).

This announcement contains regulated information as per Disclosure Guidance and Transparency Rule (DTR) 6.3.

 

-ends-

 

Enquiries:

Media:

Andrew Reid

+44 (0)7800 694 276

Sarah Swailes

Marion Fischer

+44 (0)7800 694 859

+44 (0)7800 693 219

Analysts:

Greg Neilson

+44 (0)7800 694 564

Joel von Sternberg

+44 (0)7384 231 238

Michael O'Hara

+44 (0)7387 234 388

 

Notes to editors

· We are the UK's only diversified insurer and we operate in the UK, Ireland and Canada. We also have international investments in India and China.

· We help our 25.2 million customers make the most out of life, plan for the future, and have the confidence that if things go wrong we'll be there to put it right.

· We have been taking care of people for more than 325 years, in line with our purpose of being 'with you today, for a better tomorrow'. In 2025, we paid £31.9 billion in claims and benefits to our customers.

· Aviva is a Living Wage, Living Pension and Living Hours employer and provides market-leading benefits for our people, including flexible working, paid carers leave and equal parental leave. Find out more at www.aviva.com/about-us/our-people

· As at 31 December 2025, total Group assets under management at Aviva Group were £454 billion and our estimated Solvency II shareholder capital surplus was £7.1 billion. Our shares are listed on the London Stock Exchange and we are a member of the FTSE 100 index.

· For more details on what we do, our business and how we help our customers, visit www.aviva.com/about-us

· The Aviva newsroom at www.aviva.com/newsroom includes links to our spokespeople images, podcasts, research reports and our news release archive. Sign up to get the latest news from Aviva by email.

· You can follow us on:

X: www.x.com/avivaplc

LinkedIn: www.linkedin.com/company/aviva-plc

Instagram: www.instagram.com/avivaplc/

· For the latest corporate films from around our business, subscribe to our YouTube channel: www.youtube.com/aviva

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR FFFVFVEISIIR
Date   Source Headline
11th Jun 20261:48 pmRNSForm 8.3- Tate & Lyle plc
11th Jun 20261:47 pmRNSForm 8.3 - DCC plc
11th Jun 202610:04 amRNSHolding(s) in Company
11th Jun 20269:00 amRNSHolding(s) in Company
11th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20261:53 pmRNSForm 8.3 - Tate & Lyle plc
10th Jun 20261:52 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
10th Jun 20261:49 pmRNSForm 8.3 - Intertek Group plc
10th Jun 20261:48 pmRNSForm 8.3 - DCC plc
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20264:00 pmRNSHolding(s) in Company
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20261:55 pmRNSForm 8.3 - DCC plc
5th Jun 20261:54 pmRNSForm 8.3 - Tate & Lyle plc
5th Jun 20261:51 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
5th Jun 20261:49 pmRNSForm 8.3 - Intertek Group plc
5th Jun 20261:48 pmRNSForm 8.3 - Bodycote plc
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20263:05 pmRNSHolding(s) in Company
4th Jun 20262:23 pmRNSForm 8.3 - Tate & Lyle plc
4th Jun 20262:22 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
4th Jun 20262:19 pmRNSForm 8.3 - Intertek Group plc
4th Jun 20262:16 pmRNSForm 8.3 - DCC plc
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20261:56 pmRNSForm 8.3 - Tate & Lyle plc
3rd Jun 20261:53 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
3rd Jun 20261:52 pmRNSForm 8.3 - Intertek Group plc
3rd Jun 20261:50 pmRNSForm 8.3 - DCC plc
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20261:48 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20264:30 pmRNSTotal Voting Rights
1st Jun 20262:17 pmRNSForm 8.3 - Tate & Lyle plc
1st Jun 20262:17 pmRNSForm 8.3 - LondonMetric Property & Schroder REIT
1st Jun 20262:14 pmRNSForm 8.3 - Intertek Group plc
1st Jun 20262:12 pmRNSForm 8.3 - Bodycote plc
1st Jun 20262:10 pmRNSForm 8.3 - DCC plc
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20262:23 pmRNSHolding(s) in Company
29th May 20261:55 pmRNSFinal Result of Tender Offer
29th May 20261:50 pmRNSForm 8.3 - Intertek Group plc
29th May 20261:50 pmRNSForm 8.3 - DCC plc
29th May 202612:57 pmRNSHolding(s) in Company
29th May 20269:10 amRNSIndicative Results of Tender Offer
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20262:39 pmRNSAdmission to Trading
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20261:51 pmRNSForm 8.3 - DCC plc
27th May 20261:51 pmRNSForm 8.3 - Intertek Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.